Intrinsic value of Stericycle - SRCL

Previous Close

$53.75

  Intrinsic Value

$67.67

stock screener

  Rating & Target

buy

+26%

Previous close

$53.75

 
Intrinsic value

$67.67

 
Up/down potential

+26%

 
Rating

buy

We calculate the intrinsic value of SRCL stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 0001), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 4.6

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
   2
   3
   4
   5
   6
   7
   8
   9
   10
   11
   12
   13
   14
   15
   16
   17
   18
   19
   20
   21
   22
   23
   24
   25
   26
   27
   28
   29
   30
   31

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  2.00
  2.30
  2.57
  2.81
  3.03
  3.23
  3.41
  3.57
  3.71
  3.84
  3.95
  4.06
  4.15
  4.24
  4.31
  4.38
  4.44
  4.50
  4.55
  4.59
  4.64
  4.67
  4.70
  4.73
  4.76
  4.78
  4.81
  4.83
  4.84
  4.86
Revenue, $m
  3,652
  3,736
  3,832
  3,940
  4,060
  4,191
  4,333
  4,488
  4,654
  4,833
  5,024
  5,228
  5,445
  5,676
  5,921
  6,180
  6,455
  6,745
  7,052
  7,376
  7,718
  8,079
  8,459
  8,859
  9,281
  9,725
  10,192
  10,684
  11,201
  11,746
Variable operating expenses, $m
  3,196
  3,257
  3,327
  3,405
  3,492
  3,587
  3,691
  3,804
  3,925
  4,055
  3,654
  3,802
  3,960
  4,128
  4,306
  4,495
  4,695
  4,906
  5,129
  5,365
  5,613
  5,876
  6,152
  6,443
  6,750
  7,073
  7,413
  7,771
  8,147
  8,543
Fixed operating expenses, $m
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -1
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
  -2
Total operating expenses, $m
  3,195
  3,256
  3,326
  3,404
  3,491
  3,586
  3,690
  3,803
  3,924
  4,054
  3,653
  3,801
  3,959
  4,127
  4,305
  4,494
  4,694
  4,905
  5,127
  5,363
  5,611
  5,874
  6,150
  6,441
  6,748
  7,071
  7,411
  7,769
  8,145
  8,541
Operating income, $m
  457
  480
  507
  536
  569
  604
  643
  685
  731
  780
  1,371
  1,427
  1,486
  1,549
  1,616
  1,687
  1,762
  1,841
  1,924
  2,013
  2,106
  2,204
  2,308
  2,417
  2,532
  2,654
  2,781
  2,915
  3,056
  3,205
EBITDA, $m
  1,139
  1,165
  1,195
  1,229
  1,266
  1,307
  1,352
  1,400
  1,452
  1,507
  1,567
  1,630
  1,698
  1,770
  1,846
  1,927
  2,013
  2,103
  2,199
  2,300
  2,407
  2,519
  2,638
  2,762
  2,894
  3,032
  3,178
  3,331
  3,493
  3,662
Interest expense (income), $m
  89
  148
  153
  158
  164
  171
  178
  186
  195
  204
  215
  226
  238
  250
  264
  278
  293
  309
  326
  344
  363
  383
  404
  426
  450
  475
  501
  528
  557
  587
  619
Earnings before tax, $m
  309
  327
  349
  372
  398
  426
  457
  490
  526
  565
  1,145
  1,189
  1,236
  1,285
  1,338
  1,394
  1,452
  1,515
  1,580
  1,650
  1,723
  1,800
  1,882
  1,968
  2,058
  2,153
  2,253
  2,358
  2,469
  2,585
Tax expense, $m
  84
  88
  94
  100
  107
  115
  123
  132
  142
  152
  309
  321
  334
  347
  361
  376
  392
  409
  427
  445
  465
  486
  508
  531
  556
  581
  608
  637
  667
  698
Net income, $m
  226
  239
  254
  272
  290
  311
  334
  358
  384
  412
  836
  868
  902
  938
  977
  1,017
  1,060
  1,106
  1,154
  1,204
  1,258
  1,314
  1,374
  1,436
  1,502
  1,572
  1,645
  1,721
  1,802
  1,887

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  7,133
  7,297
  7,485
  7,696
  7,929
  8,185
  8,464
  8,765
  9,090
  9,439
  9,813
  10,211
  10,635
  11,085
  11,564
  12,070
  12,607
  13,174
  13,773
  14,406
  15,074
  15,778
  16,521
  17,303
  18,126
  18,994
  19,907
  20,867
  21,878
  22,941
Adjusted assets (=assets-cash), $m
  7,133
  7,297
  7,485
  7,696
  7,929
  8,185
  8,464
  8,765
  9,090
  9,439
  9,813
  10,211
  10,635
  11,085
  11,564
  12,070
  12,607
  13,174
  13,773
  14,406
  15,074
  15,778
  16,521
  17,303
  18,126
  18,994
  19,907
  20,867
  21,878
  22,941
Revenue / Adjusted assets
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
  0.512
Average production assets, $m
  3,514
  3,594
  3,687
  3,790
  3,905
  4,031
  4,169
  4,317
  4,477
  4,649
  4,833
  5,029
  5,238
  5,460
  5,696
  5,945
  6,209
  6,489
  6,784
  7,096
  7,425
  7,772
  8,137
  8,522
  8,928
  9,355
  9,805
  10,278
  10,776
  11,299
Working capital, $m
  -73
  -75
  -77
  -79
  -81
  -84
  -87
  -90
  -93
  -97
  -100
  -105
  -109
  -114
  -118
  -124
  -129
  -135
  -141
  -148
  -154
  -162
  -169
  -177
  -186
  -194
  -204
  -214
  -224
  -235
Total debt, $m
  2,830
  2,926
  3,036
  3,160
  3,296
  3,446
  3,610
  3,787
  3,977
  4,182
  4,400
  4,634
  4,882
  5,146
  5,426
  5,723
  6,038
  6,370
  6,721
  7,092
  7,484
  7,896
  8,331
  8,790
  9,272
  9,780
  10,315
  10,878
  11,471
  12,093
Total liabilities, $m
  4,180
  4,276
  4,386
  4,510
  4,646
  4,796
  4,960
  5,137
  5,327
  5,531
  5,750
  5,984
  6,232
  6,496
  6,776
  7,073
  7,388
  7,720
  8,071
  8,442
  8,833
  9,246
  9,681
  10,139
  10,622
  11,130
  11,665
  12,228
  12,820
  13,443
Total equity, $m
  2,953
  3,021
  3,099
  3,186
  3,283
  3,389
  3,504
  3,629
  3,763
  3,908
  4,062
  4,227
  4,403
  4,589
  4,787
  4,997
  5,219
  5,454
  5,702
  5,964
  6,241
  6,532
  6,840
  7,163
  7,504
  7,863
  8,241
  8,639
  9,057
  9,497
Total liabilities and equity, $m
  7,133
  7,297
  7,485
  7,696
  7,929
  8,185
  8,464
  8,766
  9,090
  9,439
  9,812
  10,211
  10,635
  11,085
  11,563
  12,070
  12,607
  13,174
  13,773
  14,406
  15,074
  15,778
  16,521
  17,302
  18,126
  18,993
  19,906
  20,867
  21,877
  22,940
Debt-to-equity ratio
  0.960
  0.970
  0.980
  0.990
  1.000
  1.020
  1.030
  1.040
  1.060
  1.070
  1.080
  1.100
  1.110
  1.120
  1.130
  1.150
  1.160
  1.170
  1.180
  1.190
  1.200
  1.210
  1.220
  1.230
  1.240
  1.240
  1.250
  1.260
  1.270
  1.270
Adjusted equity ratio
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414
  0.414

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  226
  239
  254
  272
  290
  311
  334
  358
  384
  412
  836
  868
  902
  938
  977
  1,017
  1,060
  1,106
  1,154
  1,204
  1,258
  1,314
  1,374
  1,436
  1,502
  1,572
  1,645
  1,721
  1,802
  1,887
Depreciation, amort., depletion, $m
  682
  685
  689
  693
  698
  703
  708
  714
  721
  728
  196
  204
  212
  221
  231
  241
  251
  263
  275
  287
  301
  315
  329
  345
  361
  379
  397
  416
  436
  457
Funds from operations, $m
  908
  924
  943
  965
  988
  1,014
  1,042
  1,072
  1,105
  1,140
  1,032
  1,072
  1,114
  1,159
  1,207
  1,258
  1,312
  1,368
  1,428
  1,492
  1,558
  1,629
  1,703
  1,781
  1,864
  1,950
  2,042
  2,138
  2,239
  2,345
Change in working capital, $m
  -1
  -2
  -2
  -2
  -2
  -3
  -3
  -3
  -3
  -4
  -4
  -4
  -4
  -5
  -5
  -5
  -5
  -6
  -6
  -6
  -7
  -7
  -8
  -8
  -8
  -9
  -9
  -10
  -10
  -11
Cash from operations, $m
  909
  926
  945
  967
  991
  1,017
  1,045
  1,075
  1,108
  1,144
  1,036
  1,076
  1,119
  1,164
  1,212
  1,263
  1,317
  1,374
  1,435
  1,498
  1,565
  1,636
  1,711
  1,789
  1,872
  1,959
  2,051
  2,147
  2,249
  2,356
Maintenance CAPEX, $m
  -139
  -142
  -146
  -149
  -153
  -158
  -163
  -169
  -175
  -181
  -188
  -196
  -204
  -212
  -221
  -231
  -241
  -251
  -263
  -275
  -287
  -301
  -315
  -329
  -345
  -361
  -379
  -397
  -416
  -436
New CAPEX, $m
  -69
  -81
  -92
  -104
  -115
  -126
  -137
  -149
  -160
  -172
  -184
  -196
  -209
  -222
  -236
  -250
  -264
  -279
  -295
  -312
  -329
  -347
  -366
  -385
  -406
  -427
  -450
  -473
  -498
  -524
Cash from investing activities, $m
  -208
  -223
  -238
  -253
  -268
  -284
  -300
  -318
  -335
  -353
  -372
  -392
  -413
  -434
  -457
  -481
  -505
  -530
  -558
  -587
  -616
  -648
  -681
  -714
  -751
  -788
  -829
  -870
  -914
  -960
Free cash flow, $m
  701
  703
  707
  714
  722
  732
  744
  758
  773
  791
  664
  684
  706
  730
  756
  783
  812
  843
  877
  912
  949
  989
  1,030
  1,075
  1,121
  1,171
  1,223
  1,277
  1,335
  1,396
Issuance/(repayment) of debt, $m
  88
  96
  110
  123
  137
  150
  163
  177
  190
  204
  219
  233
  248
  264
  280
  297
  314
  332
  351
  371
  391
  413
  435
  458
  483
  508
  535
  563
  592
  623
Issuance/(repurchase) of shares, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  88
  96
  110
  123
  137
  150
  163
  177
  190
  204
  219
  233
  248
  264
  280
  297
  314
  332
  351
  371
  391
  413
  435
  458
  483
  508
  535
  563
  592
  623
Total cash flow (excl. dividends), $m
  789
  799
  817
  837
  859
  882
  908
  935
  964
  995
  882
  917
  955
  994
  1,036
  1,080
  1,127
  1,176
  1,228
  1,283
  1,340
  1,401
  1,465
  1,533
  1,604
  1,679
  1,757
  1,840
  1,927
  2,019
Retained Cash Flow (-), $m
  -57
  -68
  -78
  -87
  -97
  -106
  -115
  -125
  -135
  -144
  -155
  -165
  -176
  -187
  -198
  -210
  -222
  -235
  -248
  -262
  -276
  -292
  -307
  -324
  -341
  -359
  -378
  -398
  -418
  -440
Prev. year cash balance distribution, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
  732
  731
  740
  750
  762
  776
  792
  810
  829
  851
  728
  753
  779
  807
  838
  870
  905
  941
  980
  1,021
  1,064
  1,110
  1,158
  1,209
  1,263
  1,320
  1,380
  1,443
  1,509
  1,579
Discount rate, %
  7.60
  7.98
  8.38
  8.80
  9.24
  9.70
  10.18
  10.69
  11.23
  11.79
  12.38
  13.00
  13.65
  14.33
  15.05
  15.80
  16.59
  17.42
  18.29
  19.20
  20.17
  21.17
  22.23
  23.34
  24.51
  25.74
  27.02
  28.37
  29.79
  31.28
PV of cash for distribution, $m
  681
  627
  581
  535
  490
  446
  402
  359
  318
  279
  202
  174
  148
  124
  102
  83
  67
  52
  40
  30
  22
  16
  11
  8
  5
  3
  2
  1
  1
  0
Current shareholders' claim on cash, %
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company's segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.

FINANCIAL RATIOS  of  Stericycle (SRCL)

Valuation Ratios
P/E Ratio 22.2
Price to Sales 1.3
Price to Book 1.6
Price to Tangible Book
Price to Cash Flow 8.4
Price to Free Cash Flow 11.1
Growth Rates
Sales Growth Rate 19.3%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 18.3%
Cap. Spend. - 3 Yr. Gr. Rate 13.3%
Financial Strength
Quick Ratio 1
Current Ratio 0.1
LT Debt to Equity 102.5%
Total Debt to Equity 105.1%
Interest Coverage 5
Management Effectiveness
Return On Assets 3.7%
Ret/ On Assets - 3 Yr. Avg. 6%
Return On Total Capital 3.5%
Ret/ On T. Cap. - 3 Yr. Avg. 6.3%
Return On Equity 7.4%
Return On Equity - 3 Yr. Avg. 12.3%
Asset Turnover 0.5
Profitability Ratios
Gross Margin 42.2%
Gross Margin - 3 Yr. Avg. 42.5%
EBITDA Margin 18.8%
EBITDA Margin - 3 Yr. Avg. 21.5%
Operating Margin 12.2%
Oper. Margin - 3 Yr. Avg. 16.8%
Pre-Tax Margin 9.2%
Pre-Tax Margin - 3 Yr. Avg. 14%
Net Profit Margin 5.8%
Net Profit Margin - 3 Yr. Avg. 9.2%
Effective Tax Rate 36.6%
Eff/ Tax Rate - 3 Yr. Avg. 34.7%
Payout Ratio 18.9%

SRCL stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the SRCL stock intrinsic value calculation we used $3580.7 million for the last fiscal year's total revenue generated by Stericycle. The default revenue input number comes from 0001 income statement of Stericycle. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our SRCL stock valuation model: a) initial revenue growth rate of 2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.6%, whose default value for SRCL is calculated based on our internal credit rating of Stericycle, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Stericycle.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of SRCL stock the variable cost ratio is equal to 87.8%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $-1 million in the base year in the intrinsic value calculation for SRCL stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 5.4% for Stericycle.

Corporate tax rate of 27% is the nominal tax rate for Stericycle. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the SRCL stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for SRCL are equal to 96.2%.

Life of production assets of 24.7 years is the average useful life of capital assets used in Stericycle operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for SRCL is equal to -2%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2896.6 million for Stericycle - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 85.888 million for Stericycle is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Stericycle at the current share price and the inputted number of shares is $4.6 billion.

RELATED COMPANIES Price Int.Val. Rating
WM Waste Manageme 90.14 53.59  sell
CLH Clean Harbors 66.99 110.01  str.buy
ECOL US Ecology 69.25 42.49  sell

COMPANY NEWS

▶ John Rogers Comments on Stericycle   [Oct-17-18 04:39PM  GuruFocus.com]
▶ 13 New Stocks in the Wide Moat Focus Index   [Oct-11-18 06:00AM  Morningstar]
▶ Why Stericycle Inc Stock Is Sinking Today   [Aug-03-18 11:39AM  Motley Fool]
▶ Stericycle (SRCL) Tops Q2 Earnings Estimates   [Aug-02-18 06:00PM  Zacks]
▶ Stericycle: 2Q Earnings Snapshot   [04:55PM  Associated Press]
▶ Is Stericycle Inc (NASDAQ:SRCL) Undervalued?   [Jun-27-18 09:03AM  Simply Wall St.]
▶ 10 Newest Stocks in the Wide-Moat Focus Index   [Jun-20-18 06:00AM  Morningstar]
▶ Product Recalls: Big Brother or Caring for One Another?   [Jun-12-18 09:00AM  PR Newswire]
▶ Stericycle to Participate in Two Investor Events in June   [Jun-05-18 05:00PM  GlobeNewswire]
▶ Stericycle: 1Q Earnings Snapshot   [May-03-18 04:23PM  Associated Press]
▶ Stericycle to Participate in Two Investor Events   [Apr-18-18 04:30PM  GlobeNewswire]
▶ Following sale of CJ Advertising, Arnie Malham hits the books   [Mar-27-18 12:30PM  American City Business Journals]
▶ Stericycle, Inc. Announces Changes to Board of Directors   [Mar-21-18 06:00PM  GlobeNewswire]
▶ Why Stericycle Stock Is Sinking Today   [Feb-22-18 01:36PM  Motley Fool]
▶ Stericycle: Restructuring Weighs, Shares Attractive   [Feb-21-18 10:10PM  Morningstar]
▶ Stericycle shares fall as earnings miss   [05:02PM  MarketWatch]
▶ Stericycle misses 4Q profit forecasts   [04:21PM  Associated Press]
▶ Stericycle, Inc. to Host Earnings Call   [12:45PM  ACCESSWIRE]
▶ Stericycle to Participate in Two Investor Events in March   [Feb-07-18 04:02PM  GlobeNewswire]
▶ T Rowe Price Equity Income Fund Establishes 4 New Positions   [Jan-16-18 01:31PM  GuruFocus.com]
▶ 6 Stocks With Negative Performances   [Dec-20-17 02:56PM  GuruFocus.com]
▶ New Strong Sell Stocks for December 1st   [Dec-01-17 08:56AM  Zacks]
▶ Stocks That Fell to 3-Year Lows in the Week of Nov. 24   [Nov-25-17 03:35PM  GuruFocus.com]
▶ New Strong Sell Stocks for November 21st   [Nov-21-17 09:31AM  Zacks]
▶ New Strong Sell Stocks for November 10th   [Nov-10-17 08:48AM  Zacks]
▶ Stericycle Sell-Off Overdone   [07:00AM  Morningstar]
▶ Stericycle Inc. Stumbled Backwards in Q3   [10:00AM  Motley Fool]
▶ Stericycle shares down 9% after quarterly sales miss   [Nov-08-17 04:55PM  MarketWatch]

CONTACT US       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2018. All rigths reserved.